Catherine Lubetzki
Corporate Officer/Principal chez ReWind Therapeutics NV
Provenance du réseau au premier degré de Catherine Lubetzki
Entité | Type d'entité | Industrie | |
---|---|---|---|
ReWind Therapeutics NV
ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Catherine Lubetzki via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director/Board Member | |
Maastricht University | College/University | Doctorate Degree | |
INSEAD | College/University | Masters Business Admin | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member | |
ABLYNX | Biotechnology | Director/Board Member | |
Gimv Life Sciences
Gimv Life Sciences Investment ManagersFinance Gimv Life Sciences (Gimv-LS) is the venture capital division of Belgium's Gimv NV (XB: GIMB), an investment firm founded in 1980. Based in Antwerp, Gimv-LS manages a variety of funds which focus on investing in European companies in the life sciences / biotech sector, including the Biotech Fonds Vlaanderen, which was established at the request of the Flemish Region to provide venture capital to existing and start-up medium and large-sized companies in the Flemish biotechnology sector. | Investment Managers | Corporate Officer/Principal | |
Roche Ventures
Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Private Equity Investor | |
Instituto de Empresa SL | College/University | Masters Business Admin | |
Freie Universität Berlin | College/University | Doctorate Degree | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Humboldt-Universität zu Berlin | College/University | Doctorate Degree | |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
Life Science Ventures
Life Science Ventures Investment ManagersFinance Life Science Ventures provides financial advice. | Investment Managers | Corporate Officer/Principal | |
Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
University of Antwerp | College/University | Graduate Degree | |
FBC Device ApS
FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Medical Specialties | Director/Board Member | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
The International Venture Club | Corporate Officer/Principal | ||
Sunstone LSV Management A/S | Director/Board Member | ||
Sunstone LSV General Partner BI ApS | Corporate Officer/Principal | ||
Sunstone LSV Partners & Co. Holding III ApS | Chief Executive Officer | ||
Sunstone LSV Partners Holding III ApS | Chief Executive Officer | ||
Sunstone LSV Invest III Holding ApS | Chief Executive Officer | ||
Sunstone LSV & Co. Special Limited Partner III Holding ApS | Chief Executive Officer | ||
Sunstone LSV Invest III ApS | Chief Executive Officer | ||
Sunstone LSV Special Limited Partner III Aps | Chief Executive Officer | ||
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
Sunstone Lsv Special Ltd. Partner Iii Holding Aps | Chief Executive Officer | ||
Acarix A/S
Acarix A/S Medical SpecialtiesHealth Technology Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark. | Medical Specialties | Director/Board Member | |
Sunstone Life Science Ventures A/S
Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The company is based in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
Parsimoneous Holding ApS
Parsimoneous Holding ApS Financial ConglomeratesFinance Parsimoneous Holding ApS functions as an investment holding Danish company. The private company is based in Gentofte, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Latentix ApS
Latentix ApS Information Technology ServicesTechnology Services Latentix ApS provides custom computer programming services. The private company is based in Frederiksberg, Denmark. | Information Technology Services | Corporate Officer/Principal | |
Sunstone Tv Lsv Special LP Ill Aps
Sunstone Tv Lsv Special LP Ill Aps Financial ConglomeratesFinance Sunstone Tv Lsv Special LP Ill Aps is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone LSV General Partner Ill ApS
Sunstone LSV General Partner Ill ApS Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone LSV General Partner Ill ApS functions as an investment holding Danish company. The company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Abinitio ApS
Abinitio ApS Financial ConglomeratesFinance Abinitio ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone Lsv General Partner Ii ApS
Sunstone Lsv General Partner Ii ApS Financial ConglomeratesFinance Sunstone Lsv General Partner Ii ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Sunstone Lsv & Co. Invest Ill Holding Aps
Sunstone Lsv & Co. Invest Ill Holding Aps Financial ConglomeratesFinance Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company. | Financial Conglomerates | Chief Executive Officer | |
ENTRADA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Asbjørn Andersson ApS | Chief Executive Officer | ||
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
BIAL-Biotech Investments, Inc. | Chief Executive Officer | ||
IO BIOTECH, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Danemark | 26 |
Belgique | 8 |
Etats-Unis | 5 |
Pays-Bas | 4 |
Allemagne | 4 |
Sectorielle
Health Technology | 18 |
Finance | 12 |
Consumer Services | 7 |
Retail Trade | 2 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 38 |
Chief Executive Officer | 19 |
Corporate Officer/Principal | 14 |
Chairman | 5 |
Private Equity Investor | 4 |
Relations les plus connectées
Insiders | |
---|---|
Claus Asbjørn Andersson | 41 |
Jim van Heusden | 22 |
Cornelis Kees | 11 |
Anja Harmeier | 10 |
- Bourse
- Insiders
- Catherine Lubetzki
- Connexions Sociétés